ABSTRACT Nuclear reprogramming, the conversion of the epigenome of a differentiated cell to one that is similar to the undifferentiated embryonic state, can be facilitated by several methods, such as nuclear transfer, cell fusion, use of embryonic stem cell extracts, and more recently, by the introduction of exogenous transcription factors. Amongst these various strategies, somatic cell nuclear transfer (SCNT) is, by far, the most effective method of nuclear reprogramming. The majority of SCNT studies have been carried out using enucleated mature oocytes, as reprogramming is efficient and can be completed within hours following the introduction of the somatic cell nuclei into the recipient oocyte. Fertilized eggs, on the other hand, were regarded as poor recipients for nuclear transfer, as previous studies showed that embryonic blastomeres transferred into enucleated zygotes were unable to develop to blastocysts. However, more recent studies have demonstrated that the method of enucleation and the cell cycle phase of the embryos can impact the success of somatic cell reprogramming when zygotes were used as nuclear recipients. It is, therefore, timely to revisit and further explore the nuclear reprogramming capacity of zygotes as recipients for SCNT. Assessment of the various factors that influence the reprogramming capacity of zygotes in SCNT also provide hints of the mechanistic nature of nuclear reprogramming.
enucleated oocytes (Table 1) . However, in the majority of cloning experiments, reprogramming of the transplanted nuclei is often incomplete, resulting in embryonic arrest, high abortion rates, defective placentas, and neonatal abnormalities in the cloned animals (Hill et al., 2000; Hill et al., 2002; Ogura et al., 2002; Ono and Kono, 2006; Young et al., 1998) .
The efficiency of SCNT is largely influenced by the reprogramming capacity of the recipient cytoplasm. Thus far, all successful mammalian cloning experiments were performed with the transfer of somatic cell/nuclei into enucleated metaphase II (MII) oocytes. These studies indicate that the ooplasm of MII oocytes contains all the necessary factors to efficiently reprogram the differentiated somatic cell nuclei and support embryonic development. It appears, however, that the reprogramming capacity of oocytes declines rapidly after ovulation, and aged oocytes cannot fully reprogram the transplanted nuclei (Hall et al., 2007; Wakayama et al., 2007) . Early experiments investigating the nuclear reprogramming capacity of fertilized eggs also indicate that the zygotic cytoplasm does not support efficient reprogramming of the transferred nuclei (Howlett et al., 1987; McGrath and Solter, 1984; Robl et al., 1986; Tsunoda et al., 1987; Wakayama et al., 2000) . It is unclear why this should be the case, given that epigenetic reprogramming of the male and female pronuclei occurs naturally upon fertilization during normal development. Were these reprogramming factors somehow degraded, sequestered or removed 
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during the nuclear transfer process? What are the differences in the cytoplasmic contents of MII oocytes and zygotes that influence the ability to reprogram? In this review, we seek to highlight new insights into the mechanism of nuclear reprogramming gleaned from recent studies investigating the use of zygotes in nuclear transfer.
Nuclear transfer into zygotes
For more than two decades, zygotes have been regarded as poor recipients for nuclear transfer. Illmensee and Hoppe reported the first successfully cloned mouse via the transfer of inner cell mass (ICM) nuclei into microsurgically enucleated zygotes (Illmensee and Hoppe, 1981) . However, the results have never been reproduced. In subsequent experiments by McGrath and Solter, nuclear transfer into zygotes was successful only when the authors performed pronuclei exchange between two fertilized zygotes but not when nuclei from cells at later embryonic stages were transferred (McGrath and Solter, 1983; McGrath and Solter, 1984) . Embryos generated by pronuclear exchange developed into blastocysts in vitro which could give rise to live born mice in vivo. In contrast, zygotes reconstructed with nuclei from preimplantation blastomeres (4-and 8-cell stages) or ICM cells failed to form blastocysts in culture. These results led to the conclusion that mouse blastomere nuclei transferred into enucleated zygotes cannot support development in vitro (McGrath and Solter, 1984 et al., 1993; Howlett et al., 1987; Meng et al., 1997; Modlinski and Smorag, 1991; Robl et al., 1986; Shinozawa et al., 2004; Smith et al., 1988a; Tsunoda et al., 1987; Wakayama et al., 2000) . In all these studies, the zygotes failed to support development to blastocysts when reconstructed with nuclei derived from cells later than two-cell stage blastomeres (Table 2) . However, the notion that zygotes are poor nuclear recipients has more recently been revised. Liveborn pups obtained from enucleated pronuclear zygotes reconstructed with interphase nuclei of 8-cell stage blastomeres were reported (Greda et al., 2006) . This was followed by a report of mice born from reconstructing metaphase zygotes, depleted of nuclear material, with chromosomes extracted from mitotically-arrested 2-cell, or 8-cell blastomeres or ES cells (Egli et al., 2007) . In addition, normal and polyspermic zygotes were shown to be capable of reprogramming the somatic genome, and supported development to blastocyst stage after reconstitution with mitotic donor cells (Egli et al., 2007; Fan et al., 2009) . In these reports, donor nuclei at corresponding stages of the cell cycle were transferred into zygotic cytoplasts enucleated at pronuclear or mitotic phase. Recent experiments, however, have demonstrated that cell cycle synchrony between donor nucleus and the recipient zygote at the time of transfer is not requisite for successful reprogramming (Egli and Eggan, 2010) . Using donor and recipient cells at different stages of the cell cycle, the authors demonstrated that the major determinant of nuclear transfer efficiency is the availability of nuclear reprogramming factors in the reconstructed embryo.
Localization of nuclear reprogramming factors
The major difference between these recent studies and previous unsuccessful attempts at using zygotes in cloning, lies in the breakdown of zygotic pronuclear structures before or upon enucleation. In the earlier studies, zygotes used as nuclear recipients were enucleated through the removal of intact pronuclei with wide-bore pipettes of 15-20 m tip diameter (Fig. 1 ). This Fig. 1 . Nuclear transfer into zygotic cytoplasts. Pronuclear zygotes are enucleated using either wide-bore (15-20 m) or narrow (1-2 m) pipettes, resulting in complete (A) or selective (B) enucleation. Metaphase-arrested zygotes are enucleated by the removal of the mitotic spindle and chromosomes (C). Zygotic cytoplasts at pronuclear or mitotic phases are reconstituted with donor nuclei at corresponding stages of cell cycle. Putative nuclear reprogramming factors (orange) are released into the cytoplasm upon breakdown of the pronuclear envelope during mitosis or through mechanical tearing by the enucleation pipette. Nuclei transferred into (A) cytoplasts will not be reprogrammed and the resultant embryos do not develop pass the first cleavage. Nuclei transferred into (B) and (C) cytoplasts will be reprogrammed and the cloned embryos can develop further.
enucleation method results in the removal of all pronuclear material. In contrast, Greda et al. reported a technique of selective enucleation where a very thin pipette with a tip diameter of 1-2 m was used to pull the pronuclear envelope out of the zygote with the chromatin attached (Greda et al., 2006) . This technique leads to tearing of the pronuclei, resulting in the release of pronuclear contents into the zygotic cytoplasm. In another study, Egli et al. used reversibly arrested mitotic zygotes as the nuclear recipient. Treatment of fertilized oocytes with nocodazole and MG-132 result in the zygotes arresting at metaphase. At this stage, the pronuclear envelope has broken down and condensed chromosomes attached to the mitotic spindle are aligned at the metaphase Injected chromosomes B C A plate. These zygotes can then be "enucleated" by removing the spindle alongside the attached chromosomes with a pipette (Egli et al., 2007) . Hence, in both selectively enucleated and metaphase zygotes, pronuclear contents were thought to become distributed in the cytoplasm (Fig. 1) .
The finding that the cytoplasm of these zygotes now exhibits reprogramming activity previously thought to be lacking, led to the hypothesis that one or more factors necessary to support nuclear reprogramming are localized in the pronuclei. Hence, enucleation techniques that lead to the release of these factors into the cytoplasm will confer reprogramming capacity to the nuclear recipients (Fig. 2) . In contrast, complete enucleation of intact pronuclei from interphase zygotes leads to the removal of these factors, leaving the cytoplasm unable to support nuclear reprogramming of the transferred somatic nuclei.
In the nuclear transfer experiments of Illmensee and Hoppe, it is unclear whether the technique of enucleation, with a pipette of 10 m in diameter, resulted in pronuclei rupture and the release of nuclear contents into the cytoplasm (Illmensee and Hoppe, 1981) . However, the hypothesized gain of reprogramming factors from leaked pronuclear material would not account for the reported differences in the developmental potential of zygotes reconstructed with nuclei of ICM versus trophectoderm (TE) cells. In addition, there are unresolved discrepancies in the pattern of glucose phosphate isomerase (GPI-1) activity in the reconstructed embryos. Oocyte-derived cytoplasmic maternal GPI-1 was inexplicably absent in these embryos, in contrast to studies that showed a distinct contribution of pre-existing maternal GPI-1 activity in reconstructed embryos (Gilbert and Solter, 1985) . Hence, even in the light of recent reports of successful nuclear transfer into zygotes, the study carried out by Illmensee and Hoppe remains unproven and controversial.
The hypothesis that reprogramming is mediated, at least in part, by molecules sequestered in the nucleus until nuclear envelope breakdown, is consistent with much of existing SCNT research. Most successful mammalian cloning were performed by SCNT into MII oocytes. This indicates the ooplasm of oocytes arrested at metaphase can support efficient nuclear reprogramming of transferred nuclei. More recently, early bovine zygotes were shown to support development of transferred somatic G1 phase nuclei when the maternal telophase II chromosomes and condensed sperm DNA were removed prior to pronuclei formation (Schurmann et al., 2006) . In addition, the cytoplasm of enucleated prometaphase I (pro-MI) stage oocytes was found to be capable of remodeling ES cell nuclei, resulting in pseudo-pronuclei formation (Gao et al., 2002) . This remodeling activity was, however, absent in germinal vesicle (GV) stage oocytes. Furthermore, selectively enucleated GV oocytes were able to support development to blastocysts when reconstructed with 2-cell blastomere nuclei, but complete enucleation abolished this ability (Mohammed et al., 2008) . Germinal vesicle material had also been shown to be required for male pronucleus formation upon fertilization of both mouse and porcine oocytes (Balakier and Tarkowski, 1980; Ogushi et al., 2005) . These findings suggest that vital reprogramming factors are contained within the germinal vesicles of these oocytes. The somatic nuclei reprogramming potential of other embryonic cell types, such as ES cells and 2-cell stage blastomeres, is also mediated by factors localized in the nucleus (Do and Scholer, 2004; Egli et al., 2009; Landsverk et al., 2002) . However, whether reprogramming factors in these cells are the same as the factors active in oocytes and zygotes is not known.
Based on the successes of embryonic cell nuclear transfer (ECNT) in selectively enucleated or metaphase zygotes, it appears likely that some components of the pronuclei are essential to the nuclear reprogramming activity in zygotes (Egli et al., 2007; Greda et al., 2006) . However, the capacity to completely reprogram and support preimplantation development after nuclear transfer likely requires multiple factors located in the nucleus as well as the cytoplasm. Recently, cytoplasmic lysates of mouse GV oocytes were shown to induce chromatin remodeling and DNA demethylation in somatic cell nuclei, and enhanced cloning efficiency when these nuclei were transferred into MII oocytes (Bui et al., 2008) . Thus, additional direct experiments will be required to determine whether factors localized in the nucleus are sufficient for the nuclear reprogramming capability of mammalian oocytes and zygotes, and to elucidate the identity of these factors.
Nuclear reprogramming during normal development
Epigenetic reprogramming is an important aspect of normal The release of nuclear components (orange) into the recipient cytoplasm, upon entry into mitosis or mechanical rupture of the nuclear envelope, is proposed to confer reprogramming capacity to the reconstructed cells. Successful nuclear transfer (NT) is indicated with (+), failed NT indicated with (-). NA, technique was not applicable; GV, germinal vesicle.
embryonic development. The male and female gametes are highly differentiated cells carrying genomes that have been epigenetically modified during the formation of primordial germ cells and gametogenesis. After fertilization, gamete-specific covalent modifications on the parental genomes have to be erased to allow incorporation of new epigenetic information permissive for the activation of embryonic transcription programs.
Reprogramming of the maternal genome is a process that takes place gradually over several cell divisions until blastocyst stage. Maternal DNA demethylation is a passive, replicationdependent process facilitated by the active exclusion of the oocyte-specific maintained in the zygote, and might be involved in preserving the DNA methylation status of the maternal genome at this stage.
The paternal genome, on the other hand, undergoes extensive remodeling in the zygote. Highly basic protamines that densely pack the sperm DNA become rapidly replaced by maternally provided histones in the zygote. This protamine-histone replacement allows the paternal genome to acquire a chromatin state that is enriched in hyper-acetylated histones (Adenot et al., 1997) . In addition, prior to the first DNA replication, the paternal chromatin contains only the replication-independent H3.3 variant, while the canonical H3.1/H3.2 histones are deposited at S phase (van der Heijden et al., 2005) . Different methylation modifications on histone H3 are also subsequently added throughout the pronuclear stages (Lepikhov and Walter, 2004; Liu et al., 2004; Santos et al., 2005) . Constitutive heterochromatin in the paternal pronuclei become marked with histone H3K27 trimethylation, facilitating the recruitment of the polycomb group PRC1 complex for transcriptional silencing of pericentric major satellites (Puschendorf et al., 2008) . The paternal DNA also undergoes a rapid active demethylation process that is completed within hours after fertilization, before the onset of DNA replication Oswald et al., 2000; Rougier et al., 1998) . The demethylation mechanism is largely undefined though it has been suggested to operate via indirect, repair-mediated pathways involving cytidine deaminases AID and Apobec1, or Gadd45a-associated nucleotide-excision repair (Barreto et al., 2007; Bhutani et al., 2010; Morgan et al., 2004; Morgan et al., 2005; Santos et al., 2002) . In support of a DNA repair-induced demethylation mechanism, phosphorylated gH2A.X, a marker of DNA strand breaks, was shown to accumulate with dynamics coinciding with 5-methylcytosine depletion on the paternal genome (Wossidlo et al., 2010) . Interestingly, a recent study has also implicated the transcription elongator complex in a direct demethylation reaction that utilizes the s-adenosylmethionine radical (Okada et al., 2010) . In addition, members of the Tet (ten-eleven translocation) protein family were shown to catalyze the conversion of 5-methylcytosine (5mC) to 5-hydroxylmethylcytosine (5hmC), which could be an intermediate step in a direct DNA demethylation process (Ito et al., 2010 , Tahiliani et al., 2009 . Despite the identification of these proteins which are potentially involved in mediating active paternal genome demethylation, the actual mechanism of the process remains to be clearly elucidated.
The histone code hypothesis puts forward the idea that different combinations of covalent modification on the N-terminal domains of histones, are recognized by other proteins which mediate downstream processes such as transcriptional activation or repression (Strahl and Allis, 2000) . Acetylation on specific lysine residues on H3 and H4 is proposed to result in open chromatin states permissive for transcription factor binding to cognate sequences to mediate gene activation. In contrast, methylation on H3K9 and H3K27, as well as DNA methylation, leads to transcriptional repression and gene silencing. The dramatic changes in the histone modification and DNA methylation status of the male and (to a lesser extent) female genomes are, therefore, presumably necessary to create diploid chromatin that is permissive for the initiation of an embryonic transcription program directed by specific transcription factors during zygotic gene activation (ZGA).
Reprogramming of transferred nuclei in zygotes
Successful cloning requires reprogramming of the transferred somatic nuclei by the recipient cell (Hiiragi and Solter, 2005) . In contrast to reprogramming of parental genomes during normal embryonic development, reprogramming of the somatic nuclei in SCNT is a much more complicated process. Aside from changing a pre-existing differentiated cell-specific transcription program to one encoding the embryonic state, other processes such as DNA methyltransferase Dnmt1o from the nucleus in preimplantation embryos, except at the 8-cell stage (Doherty et al., 2002; Grohmann et al., 2005) . The failure to maintain methylation on newly replicated DNA leads to gradual global demethylation except at certain protected regions such as imprinted genes, pericentric heterochromatin, and some endogenous retroviral loci (Armstrong et al., 2006) . The maternal genome is prepackaged with histones in the oocyte, and has a chromatin configuration containing high levels of H3 histones methylated on lysines 4, 9 and 27, and trimethlyated histone H4 lysine 20. (Erhardt et al., 2003; Lepikhov and Walter, 2004; Liu et al., 2004; van der Heijden et al., 2005) . In particular, DAPIintense pericentric chromatin marked by H3K9me3 and H4K20me3 is present only on the maternal pronuclei (Puschendorf et al., 2008; Santos et al., 2005; van der Heijden et al., 2005) . These histone methylation states are reversal of X-inactivation and telomere extensions must take place post-zygotically to restore totipotent developmental potential. For the purposes of this review, however, we will discuss only the reprogramming events that are required prior to the initiation of ZGA. For SCNT in mouse zygotes to be successful, the somatic genome must undergo changes to permit the precise expression of the embryonic transcription program initiated during ZGA at the two-cell stage. Hence, reprogramming of somatic nuclei requires 1) loss of differentiated cell-specific transcription and chromatin factors, particularly at repressed embryonic gene loci, 2) appropriate changes to DNA methylation and histone modification patterns, 3) chromatin remodeling via nucleosomal positioning and exchange of H1 linker histones, and 4) binding of embryonic transcription factors to activate embryonic gene expression (Fig.  3) . These reprogramming events would have to occur in the time the reconstructed embryo takes to develop from the transcriptionally quiescent state of the zygote, to major ZGA at the 2-cell stage. For nuclear transfer into interphase zygotes, this process takes approximately 24 hrs, while reconstructed metaphase zygotes undergo the first cell cleavage just 120 min after chromosome transfer (Egli et al., 2007) .
Disassociation of somatic transcriptional regulators from transferred nuclei
The somatic nucleus carries not only chromosomal DNA but also proteins involved in maintaining the identity of the cell from which it was taken. Transcriptional activators are bound at somatic gene loci, while repressors and co-repressors are associated at embryonic gene regions to keep them transcriptionally silenced. The activation of the embryonic transcription program and reprogramming of somatic nuclei to a totipotent state requires a reciprocal binding of transcriptional activators and repressors. Hence, removal of somatic DNA-and chromatin-associated proteins is necessary to allow embryonic regulatory factors to access and activate or repress a new set of genes. Indeed, nuclear swelling is observed in somatic nuclei transferred into oocytes and interphase zygotes, indicative of extensive exchanges of proteins between the cytoplasm and the transferred nuclei. It has also been shown that transcription factors and chromatinassociated proteins such as TATA-box binding protein (TBP), histone deacetylase (HDAC2), and the ATP-dependent chromatin remodeler Brahma-related gene 1 (Brg1) are lost from the somatic nuclei and dispersed into the oocyte cytoplasm within 2 hrs of nuclear transfer, at the time of premature chromosome condensation . Results from the chromosome transfer experiments performed by Eggan and colleagues also support the view that the loss of transcriptional activators and repressors during mitosis could be a critical reprogramming event (Egli et al., 2008) . During mitosis, many sequence-specific transcription factors such as HSF1, Sp1, and C/EBP, as well as some basal factors (TFIIB, TAF1 and TBP) were found to dissociate from the condensed chromosomes (Martinez-Balbas et al., 1995; Sun et al., 2007) . Likewise, transcriptional repressors such as heterochromatin protein 1 (HP1), BMI-1 and other polycomb group proteins were also detached from the mitotic chromosomes (Hayakawa et al., 2003; Minc et al., 1999; Miyagishima et al., 2003; Murzina et al., 1999; Voncken et al., 1999) . Extensive dissociation of transcriptional regulators from the somatic nuclei and chromosomes upon nuclear transfer allows the DNA to become more accessible to other factors present in the recipient zygotes, thus enhancing the reprogramming process. Recently, it was found that the efficiency of reprogramming could be correlated to the degree of dissociation of TBP, TFIIB and HP1 from somatic nuclei transferred into MII-oocytes . Hence, depletion of somatic DNA-transcriptional regulator interactions is likely to be an essential reprogramming event during SCNT.
Epigenetic modifications of DNA and histones
During reprogramming, the somatic nuclei also have to undergo extensive changes in DNA methylation and histone modification patterns to erase the existing differentiated cell-specific marks and acquire a new set of epigenetic information. However, the somatic genome, already packaged with histones, is unlikely to undergo the massive histone replacement process observed with the paternal genome. As extensive nucleosomal protein exchanges seems unlikely to occur during mitosis, the finding that the transfer of highly condensed mitotic chromosomes into metaphase zygotes can result in successful ECNT (Egli et al., 2007) , also argues against a large-scale histone replacement process. Instead, the somatic nuclei were observed to undergo dynamic changes in histone acetylation and methylation patterns which are developmentally regulated in reconstructed MII-oocytes (Wang et al., 2007) . These changes would have to be carried out by specific histone modifying enzymes localized in the nucleus. These specific histone modifiers could be dispersed into the zygotic cytoplasm upon pronuclear membrane breakdown, and contribute to the reprogramming activities observed in metaphase or selectively enucleated zygotes. DNA demethylation is another important aspect of epigenetic remodeling in the zygote. Demethylation of the Pou5f1 promoter region was found to be critical for re-activation of Oct4 gene expression from mammalian somatic nuclei transferred into Xenopus oocytes (Simonsson and Gurdon, 2004) . Thus, incomplete DNA demethylation is proposed to be a major cause of SCNT failure. Though the DNA methylation profiles of almost all cloned embryos/animals were found to be aberrant, analysis of DNA methylation in cloned bovine embryos provided a hint that active demethylation of the somatic nuclei potentially occurs in the zygote (Dean et al., 2001; Kang et al., 2001) . It was observed that somatic pseudo-pronuclei, resulting from the transfer of highly methylated fibroblast nuclei into enucleated oocytes and activation, stained much less strongly with an antibody to 5-methylcytosine compared to the female pronucleus in a normal zygote (Dean et al., 2001) . While the extent and location of demethylation is unclear from the study, this observation nevertheless suggests that the somatic nuclei may be demethylated by the same proteins that mediate active paternal genome demethylation (Dean et al., 2001) . Given the observed differences in the reprogramming efficiency of MII-oocytes and zygotes, it will be interesting to further examine the DNA methylation profiles in cloned embryos derived from reconstructed interphase and metaphase zygotes.
Chromatin remodeling through H1 linker histone exchange
Linker histone H1 is generally thought to be a repressive component of chromatin due to its function in mediating higher order nucleosomal assembly. Apart from the somatic H1 isoform, oocyte-specific H1 linker histones have been identified in amphibians and mammals (Smith et al., 1988b; Tanaka et al., 2001) . During normal development, oocyte-specific H1foo linker histones are present in oocytes and embryos until ZGA, when they become replaced by somatic H1 on the chromatin. The oocytespecific H1foo histones have different properties from the somatic H1, and are proposed to mediate a more fluid chromatin structure during early embryogenesis (Saeki et al., 2005) . Recently, it has been shown that H1 linker histones are rapidly replaced by oocyte-specific H1foo in somatic nuclei transferred into mammalian MII-oocytes (Bordignon et al., 1999; Gao et al., 2004; Teranishi et al., 2004) . Interestingly, the H1-H1foo exchange appears to be critical for pluripotency gene activation during SCNT in Xenopus oocytes (Jullien et al., 2010) . It is unclear if this pattern of H1 transition occurs during SCNT into enucleated mammalian zygotes. However, as it seems unlikely that extensive linker histone replacements would take place in condensed mitotic chromosomes, it would appear that H1-H1foo transition might not be essential for successful nuclear reprogramming in mammalian zygotes. The significance of the somatic to oocyte-specific H1 transition in nuclear reprogramming by mammalian oocytes is also uncertain given that the transition was observed in all cloned mouse embryos, of which less than 2-3% are able to develop to term (Gao et al., 2004) .
Activation of gene expression by embryonic transcription factors
Transcription factors are critical regulators of gene expression, and very likely play the principal role in directing cell-type specific transcription programs. The dominant action of a master transcription factor could potentially override the pre-existing cellspecific gene expression profile, and lead to a change in cell identity. This was demonstrated by the induction of a muscle-cell gene expression pattern in a range of different non-muscle cell types with the over-expression of a single transcription factor, MyoD (Weintraub et al., 1989) . More recently, ectopic expression of four transcription factors, Oct4, Sox2, Klf4, and c-Myc was found to be sufficient to revert differentiated fibroblasts to pluripotent, embryonic stem cell-like cells (Takahashi and Yamanaka, 2006 ). Further refinement of the induced pluripotent stem cell methodology reveals the requirement for only Oct4 and Sox2 in the reprogramming process (Huangfu et al., 2008) . These two transcription factors are maternally expressed in oocytes and zygotes, and should be readily available during SCNT to direct the activation of the embryonic gene expression program in the somatic nuclei. Successful nuclear transfer into zygotes suggest that these and other key embryonic transcription regulators might have been removed during complete enucleation of intact pronuclei (Egli et al., 2007; Greda et al., 2006) . Breakdown of the nuclear envelope during selective enucleation or entry into mitosis would release these factors into the zygotic cytoplasm, thus conferring reprogramming capacity.
Although other reprogramming events such as DNA demethylation, changes to histone post-translational modifications and H1 linker histone exchanges occur during SCNT, these processes were often found to be partial and aberrant, even in the cloned animals that developed to term. These observations suggest that even if epigenetic reprogramming of the somatic nuclei is incomplete, master transcriptional regulators, present at sufficient levels in the nuclear recipients, are able to supersede unfavorable chromatin states, and activate appropriate embryonic gene expression for the development of reconstructed embryos (Egli et al., 2008) . If this hypothesis is true, one should then be able to successfully reprogram somatic nuclei in completely enucleated zygotic cytoplasts that are supplemented with the right set of transcriptional regulators. However, such experiments will be fraught with challenges in the identification of the appropriate transcription factors, control of delivery, expression and amounts of factors to be introduced, and accurate analysis of the developmental outcome.
Conclusions
In this review, we have focused our discussion on the nuclear reprogramming capacity in zygotes. After two decades of unsuccessful attempts to use zygotes in mammalian cloning experiments, it has been demonstrated that soluble nuclear contents appeared to contain the major reprogramming activities (Egli et al., 2007; Greda et al., 2006) . Given the complexity of somatic nuclei reprogramming, it is somewhat surprising to find that this process can be successfully completed in the short period of time from the introduction of mitotic chromosomes into metaphase zygotes to the activation of embryonic transcription in 2-cell stage embryos. However, the reprogramming process remains much less efficient in zygotes than in MII-oocytes. While a greater than 4% success rate (calculated as number of live-borns out of total reconstructed embryos) was reported when genomic material of 8-cell blastomeres was transferred into selectively enucleated or metaphase zygotes, SCNT into zygotes did not result in any liveborn animals (Egli et al., 2007; Greda et al., 2006) . It remains to be determined if the low success rates of reprogramming by zygotes can be improved by further technical advancements or are the results of the intrinsic properties of these recipient cells. Additional experiments are also required to address what cytoplasmic factors, if any, are vital complements to the nuclear factors. SCNT using zygotes provides a platform to assay for critical reprogramming factors and identify crucial processes correlated with normal development. A clear knowledge of the mechanistic nature of reprogramming is essential for our understanding of mammalian development. There is also significant medical interest in having a better comprehension of how cells can be modified from one cell type to another, with the ultimate goal of generating patient-specific cells that can be used in disease therapy via direct reprogramming. 
